TAKHZYRO (Takeda Pharmaceutical Company)
(https://takhzyro.com) 📸 Data Snapshot: May 29, 2026Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
The site displays a review_count of 6 on the patient stories page with a trust_theatre_flag of true, yet has a proof_links_count of 0, meaning these testimonials are hosted without verifiable external paths. The claim of being the ‘#1 prescribed’ treatment is backed only by ‘third-party US specialty pharmacy data’ without a specific link to the study or report. Furthermore, the statistics cited are from 2018, making the proof ‘stale’ (96 months old) relative to the 2026 temporal anchor.
The ratio of evidence to assertions is moderate; for every specific statistic like ‘4000+ patients’, there are multiple unverified claims about ‘reimagining life’. The lack of external citations to ClinicalTrials.gov or PubMed for the lanadelumab-flyo efficacy results in this specific data snippet creates a proof vacuum. The presence of 50% broken pages during the audit further degrades the density of accessible evidence.
Trust & Proof is read by weighing trust language against real verification. Below is the page-by-page tally of review mentions and external proof links, then the schema markup that may (or may not) declare verifiable ratings and identity proof.
🛡️ Trust Signals — reviews, proof links, trust-theatre check
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /patient-stories/ | 6 | 0 |
| /why-takhzyro/family-treatment/ | 0 | 0 |
| /modals/stay-connected/ | 0 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: declared ratings, reviews & identity proof
This page presents a snapshot of public data from TAKHZYRO (Takeda Pharmaceutical Company), captured on May 29, 2026, to show how machine logic reads Trust & Proof signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to TAKHZYRO (Takeda Pharmaceutical Company): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://takhzyro.com to view the most current version of its content and see directly what this company is about and what it offers.